Clinical Trials on NOMID

Total 4 results

Novartis Pharmaceuticals
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Terminated

Canakinumab to Treat Neonatal-Onset Multisystem Inflammatory Disease

NOMID | CINCA Syndrome

United States
Hannover Medical School

Completed

Intra-arterial Prostaglandin Therapy in Non-occlusive Mesenteric Ischemia (REPERFUSE)

Non-Occlusive Mesenteric Ischaemia (NOMI)

Germany
National Institute of Allergy and Infectious Diseases...

Recruiting

Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still'S-like Diseases, and Other Undifferentiated Autoinflammatory Diseases)

DIRA | NLRC4-MAS | NOMID | SAVI | CANDLE

United States
Novartis Pharmaceuticals

Completed

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients (B-Confident)

Cryopyrin-associated Periodic Syndromes (CAPS) | Familial Cold Autoinflam Syn (FCAS) | Muckle-wells Syn (MWS) | Neonatal Onset Multisystem Inflam Disease (NOMID)

Switzerland, United States, Germany, Norway, Austria

3

Subscribe